ClinicalTrials.Veeva

Menu
C

Centrum Medyczne ALL-MED Badania Kliniczne | Krakow, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Clascoterone
Rocatinlimab
CDX-0159
Upadacitinib
ABP 654
Ruxolitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis (TRuE-AD5)

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate at...

Active, not recruiting
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Ruxolitinib

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Enrolling
Alopecia Areata
Drug: Placebo
Drug: Upadacitinib
Locations recently updated

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to pla...

Enrolling
Cold-Induced Urticaria
Chronic Inducible Urticaria
Drug: Matching Placebo
Drug: Barzolvolimab
Locations recently updated

The purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous...

Invitation-only
Chronic Spontaneous Urticaria
Biological: barzolvolimab
Other: Standard of Care

Trial sponsors

Amgen logo
Celldex Therapeutics logo
AbbVie logo
C
Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems